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Abstract 
Background: Parasite prevalence is a key metric used to quantify the burden of malaria and assess the impact of 
control strategies. Most published estimates of parasite prevalence are based on microscopy and likely underestimate 
true prevalence.
Methods: Thick smear microscopy was performed in cohorts of children (aged 6 month to 10 years) and adults every 
90 days over 2 years, at three sites of varying transmission intensity in Uganda. Microscopy-negative samples were 
tested for sub-microscopic parasitaemia using loop-mediated isothermal amplification (LAMP). Generalized estimat-
ing equation models were used to evaluate associations between age and parasitaemia, factors associated with sub-
microscopic infection and associations between parasitaemia and haemoglobin.
Results: A total of 9260 samples were collected from 1245 participants. Parasite prevalence among children across 
the three sites was 7.4, 9.4 and 28.8 % by microscopy and 21.3, 31.8 and 69.0 % by microscopy plus LAMP. Parasite 
prevalence among adults across the three sites was 3.1, 3.0 and 5.2 % by microscopy and 18.8, 24.2 and 53.5 % by 
microscopy plus LAMP. Among those with parasitaemia, adults and persons recently treated with anti-malarial therapy 
had the highest prevalence of sub-microscopic infection. Children with sub-microscopic or microscopic parasitaemia 
had lower mean haemoglobin levels compared to children with no detectable parasites.
Conclusions: Across a range of transmission intensities in Uganda, microscopy vastly underestimated parasite preva-
lence, especially among adults.
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Background
Considerable progress has been made in the past decade 
in reducing the burden of malaria in Africa, largely due 
to interventions such as long-lasting, insecticide-treated 
nets (LLIN) and use of artemisinin-based combination 
therapy (ACT) [1]. However, accurately identifying and 
targeting the human reservoir of malaria parasitaemia 
remains a critical step to reducing the burden of malaria 
worldwide. This is true not only in low transmission set-
tings approaching elimination, but also in highly endemic 
countries, where repeated infections cause a partial non-
sterilizing immunity to malaria and a large proportion of 
infections may be asymptomatic.
The majority of published surveys of malaria para-
site prevalence underestimate true prevalence due to 
the low sensitivity of microscopy and rapid diagnostic 
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tests (RDTs), which have limited ability to detect para-
sitaemia  <100 parasites/µL [2, 3]. Molecular techniques 
such as PCR are more sensitive [3], and a newer molecu-
lar technique, loop-mediated isothermal amplification 
(LAMP), has an estimated lower limit of detection of 1–5 
parasites/µL [4]. LAMP has been used to estimate preva-
lence in field settings [5–7], and offers a simple tool for 
addressing the sub-microscopic malaria reservoir. There 
is an increasing awareness of implications of sub-micro-
scopic infection, including an appreciation that sub-
microscopic infections can be prominent contributors to 
malaria transmission [8, 9].
In order to estimate the prevalence of microscopic and 
sub-microscopic parasitaemia across different transmis-
sion intensities in Uganda, repeated sampling of a cohort 
of children and adults was performed with microscopy 
and LAMP in three different epidemiologic settings over 
2  years. Relationships between age and prevalence of 
parasitaemia, as well as between parasitaemia and mean 
haemoglobin, were evaluated, with the hypothesis that 
microscopy would underestimate parasite prevalence 
compared to LAMP, in all age groups and epidemiologic 
settings and that participants with microscopic and sub-
microscopic parasitaemia would have lower mean hae-
moglobin than those with no infection.
Methods
Study sites
The study was conducted in Nagongera sub-county, 
Tororo District in eastern Uganda, Walukuba sub-
county, Jinja District in eastern Uganda and Kihihi 
sub-county, Kanungu District in southwestern Uganda. 
Study clinics were set up at health centre facilities that 
serve each of the sub-counties. Nagongera and Kihihi 
sub-counties are predominantly rural and have higher 
malaria transmission intensities, while Walukuba is 
peri-urban, with the lowest transmission intensity of the 
three sites [10].
Study design and participants
Enrolment of cohorts has been described previously [10, 
11]. Briefly, participants were recruited from 100 ran-
domly selected households within the catchment area 
of the participating health facility at each of the three 
sites. All children aged 6  months to 10  years and a pri-
mary adult caretaker in a household were enrolled. As 
the cohort aged, all children that reached 6  months of 
age were dynamically enrolled and children ≥11 years of 
age were excluded from further follow-up. Participants 
agreed to come to the study clinic for any febrile illness 
and to avoid anti-malarial medications administered out-
side the study. All enrolled participants were also given a 
LLIN.
Clinical follow‑up and study time period
Study participants attended the clinic at enrolment and 
then every 90  days for routine visits. At routine visits, 
they received a history and physical examination and 
blood was obtained for haemoglobin measurement, 
thick blood smear and dried blood spots (DBS) on fil-
ter paper. RDTs were not performed. Participants who 
reported a history of fever in the previous 24 h or had a 
tympanic temperature ≥38.0 °C, and had a positive blood 
smear, were diagnosed with malaria and treated with 
artemether-lumefantrine. For this analysis, all routine 
clinic visits from 1 August, 2011 to 30 September, 2013 
were included.
Laboratory methods
Haemoglobin was estimated from finger-prick blood 
samples using a portable spectrophotometer. Thick blood 
smears were prepared with 2  % Giemsa. Light micros-
copy was performed by an experienced laboratory tech-
nician who was not involved in direct patient care. A 
second technician verified all microscopy results and a 
third technician resolved discrepancies, if needed.
DBS specimens were prepared by spotting whole blood 
onto filter paper and drying completely. LAMP testing 
was performed on all DBS specimens for which a par-
ticipant had a negative blood smear. DNA was extracted 
for LAMP using Chelex, as previously described (10). 
LAMP was performed using Eiken Loopamp™ Malaria 
Pan Detection Kit reaction tubes, which contain vacuum-
dried reagents specific for amplification of Plasmodium 
species mitochondrial DNA, per manufacturer’s guide-
lines [12]. Results of LAMP reactions were based on vis-
ual detection of fluorescence under an ultraviolet lamp. 
Three controls with known parasite densities were used 
(10 parasites/µL, 1 parasite/µL and 0 parasite/µL), as well 
as LAMP kit positive and negative controls. LAMP reac-
tions were rejected and then repeated if controls did not 
produce their expected results.
Data management and statistical analysis
Data were analysed using STATA (version 13; STATA 
Corp., College Station, TX, USA). The primary outcomes 
of interest were: (1) microscopic parasitaemia, defined 
as the proportion of routine visits with a positive blood 
smear, with or without fever; (2) sub-microscopic parasi-
taemia, defined as the proportion of routine visits with a 
negative blood smear and positive LAMP reaction; and, 
(3) any parasitaemia, defined as the proportion of routine 
visits with either positive blood smear or positive LAMP 
reaction. Generalized estimating equation models were 
used to estimate associations between age and parasitae-
mia, to assess independent predictors of sub-microscopic 
parasitaemia and to estimate the association between 
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parasitaemia and mean haemoglobin, using exchange-
able correlation structure, log link and robust standard 
error estimates. Within subject clustering was specified 
to account for repeated episodes of parasitaemia in par-
ticipants. For models looking at the association of age 
with prevalence of parasitaemia, the highest prevalence 
group for each site was chosen as the reference group. A 
p value <0.05 was considered statistically significant.
Results
Characteristics of the study site
Characteristics of the three study sites are presented in 
Table  1. Entomologic data have been described previ-
ously [10]. The annual entomological inoculation rate 
(aEIR) was lowest in Walukuba, with 2.8 infective bites 
per person per year and was approximately ten-fold 
higher in Kihihi and 100-fold higher in Nagongera, 
reflecting variation in transmission intensity among the 
three sites.
In total, 1245 participants were enrolled, with roughly 
equivalent proportions of child and adult participants at 
each site and similar mean age and gender at each site. 
Greater than 90  % of adult participants at all sites were 
female, because most adult primary caregivers enrolled 
from each household were female. Participants visited 
the clinic for routine evaluation every 90  days, contrib-
uting 2652, 3372 and 3236 routine visits in Walukuba, 
Kihihi and Nagongera, respectively.
Consistent with aEIR findings, parasite prevalence var-
ied between sites (Table 1). Parasite prevalence detected 
by microscopy was 7.4, 9.4 and 28.8 % among children in 
Walukuba, Kihihi and Nagongera, respectively (p = 0.02 
for comparison between Walukuba and Kihihi, p < 0.001 
for other pair-wise comparisons) and 3.1, 3.0 and 5.2  % 
among adults (p = 0.04 for Walukuba versus Nagongera, 
p  =  0.03 for Kihihi versus Nagongera, p  =  0.90 for 
Walukuba versus Kihihi). When both microscopy and 
LAMP were used to detect parasitaemia, parasite preva-
lence was much higher than when only microscopy was 
used, with a prevalence of 21.3, 31.8 and 69.0 % for chil-
dren (p  <  0.001 for all pair-wise comparisons between 
sites) and 18.8, 24.2 and 53.5 % for adults (p =  0.01 for 
Walukuba versus Kihihi, p < 0.001 for all other pair-wise 
comparisons).
Age trends of parasitaemia
The relationship between age and the prevalence of 
microscopic parasitaemia varied depending on transmis-
sion intensity, although at all sites prevalence increased 
from infancy to later in childhood and declined in adults 
(Table 2). In Walukuba, the lowest transmission setting, 
the prevalence of microscopic parasitaemia was lowest 
in the 6  months to  <2  years age group and was signifi-
cantly lower among individuals ages 6 months to <2 years 
and  ≥18  years compared to those aged 2 to  <5  years. 
However, in the higher transmission settings of Kihihi 
and Nagongera, prevalence of microscopic parasitaemia 
was lowest among adults. This was particularly striking in 
Nagongera, with a prevalence of 16.0 % among 6 months 
to <2 years olds versus a prevalence of 5.2 % among adults 
(p < 0.001). Both 6 months to <2 years olds and ≥18 year 
olds in Kihihi and Nagongera had a significantly lower 
prevalence of microscopic parasitaemia than a reference 
group of 5 to <11 years olds.
The relationship between age and parasitaemia was 
slightly different when considering any parasitaemia, 
including both microscopic and sub-microscopic infec-
tion (Table  3). In Walukuba, the lowest transmission 
site, the age trend was similar to that of microscopic 
parasitaemia. Children 6  months to  <2  years had a sig-
nificantly lower prevalence of parasitaemia, compared 
to the 2 to <5 years reference group, who had the high-
est prevalence of parasitaemia; the prevalence of parasi-
taemia declined for older children and adults, but these 
relative risks were not significant. At the higher trans-
mission sites of Kihihi and Nagongera, the prevalence of 
parasitaemia was also lowest among children 6  months 
to <2 years. In contrast to Walukuba, however, the preva-
lence of any detectable parasitaemia among adults in 
Kihihi and Nagongera did not follow the same pattern as 
the microscopy data. Instead of adults being the lowest 
prevalence group, as was true for microscopic parasitae-
mia, when both LAMP and microscopy were considered, 






Number of study participants
Children 283 336 311
Adults 114 95 106
Number of female participants, n (%)
Children 138 (48.8 %) 171 (50.9 %) 141 (45.3 %)
Adults 107 (93.9 %) 92 (96.8 %) 98 (92.5 %)
Age in years at the time of routine visits, mean (SD)
Children 5.2 (2.7) 5.6 (2.8) 5.6 (2.7)
Adults 33.7 (9.9) 39.0 (13.8) 39.1 (13.5)
Number of routine visits 2652 3372 3236
Parasite prevalence by microscopy  (%)
Children 7.4 9.4 28.8
Adults 3.1 3.0 5.2
Parasite prevalence by microscopy + LAMP (%)
Children 21.3 31.8 69.0
Adults 18.8 24.2 53.5
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adults had a similar prevalence of parasitaemia to that of 
infants.
Factors associated with sub‑microscopic infection, 
among those with any parasitaemia
The majority of parasitaemia detected in this study was 
sub-microscopic, across all ages and settings (Fig.  1). 
Among children with any parasitaemia, the proportion 
of infections that were sub-microscopic was highest in 
Kihihi at 69.7  %, compared to 61.5  % in Walukuba and 
59.1  % in Nangongera (p  =  0.01 for Walukuba versus 
Kihihi, p < 0.001 for Kihihi versus Nagongera, p =  0.44 
for Walukuba versus Nagongera). Among parasitaemic 
adults, the only significant difference between sites in the 
proportion of sub-microscopic infections was between 
Walukuba and Nagongera (83.2 versus 90.1 %, p = 0.04).
Among parasitaemic children, there was no signifi-
cant association demonstrated between sub-microscopic 
parasitaemia and age category (Table 4). Compared to a 
reference group aged 5 to <11 years, parasitaemic adults 
were more likely to have sub-microscopic infection, at 
all sites. The effect of age  ≥18  years on the prevalence 
of sub-microscopic parasitaemia was most dramatic in 
the medium- and highest-transmission sites, with >90 % 
of all detectable infections in Nagongera adults due to 
sub-microscopic parasitaemia. Compared to those not 
recently treated, a history of being diagnosed and treated 
for malaria in the past 30 days was associated with a sig-
nificantly greater prevalence of sub-microscopic parasi-
taemia among those who were parasitaemic, at all sites.
Associations between parasitaemia status 
and haemoglobin
Among children in all sites, mean haemoglobin was sig-
nificantly lower in those with any parasitaemia, compared 
to the group with no detectable parasitaemia (Table  5). 
There was a step-wise decrease in mean haemoglobin 
in children from microscopic to sub-microscopic to no 
detectable infection. These differences remained signifi-
cant when participants with febrile episodes of malaria 
were excluded from the analysis. For adults, a similar 
trend was demonstrated in Walukuba and Kihihi, with 
a significantly lower mean haemoglobin demonstrated 
among those with microscopic parasitaemia in Walukuba 
and a lower mean haemoglobin in those with sub-
microscopic parasitaemia and microscopic parasitaemia 
Table 2 Associations between age and prevalence of microscopic parasitaemia, stratified by study site
Relative risk is adjusted for repeated measures in the same study participant




Prevalence RR (95 % CI) p value Prevalence RR (95 % CI) p value Prevalence RR (95 % CI) p value
0.5– <2 6/247 (2.4 %) 0.36 (0.17–0.74) 0.005 14/294 (4.8 %) 0.43 (0.23–0.80) 0.007 42/263 (16.0 %) 0.51 (0.37–0.71) <0.001
2– <5 56/666 
(8.4 %)
Reference group 71/843 (8.4 %) 0.76 (0.56–1.05) 0.093 189/740 
(25.5 %)
0.77 (0.65–0.91) 0.002











0.37 (0.21–0.64) <0.001 23/765 (3.0 %) 0.28 (0.17–0.45) <0.001 44/853 (5.2 %) 0.15 (0.11–0.22) <0.001
Table 3 Associations between age and prevalence of any parasitaemia, stratified by study site
Relative risk is adjusted for repeated measures in the same study participant




Prevalence RR (95 % CI) p value Prevalence RR (95 % CI) p value Prevalence RR (95 % CI) p value
0.5– <2 31/247 (12.6 %) 0.62 (0.44–0.88) 0.008 52/294 (17.7 %) 0.55 (0.40–0.76) <0.001 129/263 
(49.1 %)
0.66 (0.58–0.75) <0.001






0.82 (0.67–0.99) 0.04 471/740 
(63.7 %)
0.85 (0.79–0.92) <0.001
5– <11 198/936 
(21.2 %)
0.79 (0.62–1.02) 0.071 548/1470 
(37.3 %)





0.76 (0.57–1.01) 0.06 185/765 
(24.2 %)
0.66 (0.51–0.85) 0.001 456/853 
(53.5 %)
0.71 (0.64–0.78) <0.001
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in Kihihi. In Nagongera, the highest transmission site, 
there was no significant difference in mean haemoglobin 
among adults, regardless of parasitaemia status.
Discussion
Presented in this report is the prevalence of microscopic 
and sub-microscopic parasitaemia in three cohorts with 
varied transmission intensity in Uganda. A highly sen-
sitive diagnostic test was used to characterize parasite 
prevalence as it relates to age, transmission intensity and 
recent anti-malarial treatment. As seen by others [2–4, 
13], microscopy dramatically underestimated malaria 
parasite prevalence. Compared to microscopy, LAMP 
increased the proportion of samples with detectable 
parasitaemia two- to ten-fold, depending on age and site. 
This study clarifies the age-specific trends of sub-micro-
scopic parasitaemia, allows these trends to be directly 
compared to those of microscopic parasitaemia and iden-
tifies factors associated with sub-microscopic infection. 
In those with detectable parasitaemia, adulthood and 
recent treatment were associated with increased preva-
lence of sub-microscopic infection. Children with either 
sub-microscopic or microscopic parasitaemia had lower 
mean haemoglobin than children with no detectable par-
asites across study sites, demonstrating the clinical rel-
evance of sub-microscopic infection.
The majority of published survey data rely on micros-
copy or RDT to generate estimates of malaria parasite 
Fig. 1 Proportion of participants with sub-microscopic parasitaemia and microscopic parasitaemia, by site. Participants are divided into sites and 
age strata along the X-axis. The proportion of positive samples, among all tested samples for that age and site, are shown on the Y-axis
Table 4 Factors associated with sub-microscopic parasitaemia if parasitaemic, stratified by study site
Relative risk is adjusted for repeated measures in the same study participant
Excludes samples from enrollment visits, for which data on malaria diagnosis in past 30 days is missing
Factor Walukuba Kihihi Nagongera
Prevalence RR (95 % CI) p value Prevalence RR (95 % CI) p value Prevalence RR (95 % CI) p value
Age groups (years)
0.5– <2 14/18 (77.8 %) 1.22 (0.94–1.58) 0.14 23/34 (67.7 %) 0.95 (0.75–1.22) 0.71 70/97 (72.2 %) 1.11 (0.96–1.29) 0.15
2– <5 81/126 (64.3 %) 1.09 (0.89–1.33) 0.41 146/206 
(70.9 %)
1.00 (0.90–1.12) 0.95 243/401 
(60.6 %)
1.02 (0.91–1.13) 0.77
5– <11 95/165 (57.6 %) Reference group 336/485 
(69.3 %)
Reference group 533/933 
(57.1 %)
Reference group
≥18 99/119 (83.2 %) 1.43 (1.20–1.71) <0.001 140/163 
(85.9 %)
1.25 (1.13–1.38) <0.001 354/393 
(90.1 %)
1.65 (1.53–1.79) <0.001
Symptomatic malaria in prior 30 days
No 263/399 
(65.9 %)
Reference group 537/761 
(70.6 %)
Reference group 987/1562 
(63.2 %)
Reference group
Yes 26/29 (89.7 %) 1.36 (1.17–1.58) <0.001 108/127 
(85.0 %)
1.27 (1.15–1.40) <0.001 213/262 
(81.3 %)
1.42 (1.31–1.55) <0.001
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prevalence. These surveys underestimate the true preva-
lence of parasitaemia since they do not detect low density 
infection [3]. Prior studies suggest that the proportion 
of sub-microscopic infections varies with transmission 
intensity and that sub-microscopic infections may pre-
dominate in low-transmission settings [14]. This study 
suggests that sub-microscopic infections make up the 
majority of detectable parasitaemia across all ages and 
transmission intensities in Uganda. Despite a dramati-
cally different overall prevalence of parasitaemia at the 
three study sites, the proportion of sub-microscopic 
infection among parasitaemic participants (59–70  % in 
children, 83–90 % in adults) was not only substantial, but 
also remarkably consistent across transmission intensi-
ties. Indeed, it is possible that due to the lower limit of 
detection of LAMP compared to more sensitive PCR-
based assays, this study underestimated the size of the 
parasite reservoir, particularly among adults, in whom 
the majority of infections were sub-microscopic and 
mean parasite densities were likely the lowest.
These data demonstrate that the prevalence of para-
sitaemia increases as children age and then declines in 
adulthood. This is a well described trend in malaria epi-
demiology [15], and consistent with previously published 
reports in this region [10, 11, 16]. However, differences in 
age trends emerged when sub-microscopic parasitaemia 
was considered in addition to microscopic parasitaemia. 
In contrast to microscopic parasitaemia, for which adults 
had the lowest prevalence in Kihihi and Nagongera, the 
prevalence of any parasitaemia was lowest at all sites in 
the youngest age group, aged 6 months to <2 years. Pub-
lished prevalence estimates for children of this age usu-
ally reflect the care of infants admitted to tertiary care 
facilities [17], or are reported combined with older age 
groups [18]. Passive immunity related to maternal anti-
bodies is thought to wane between 6 and 12 months [19, 
20], but the nadir prevalence of parasitaemia in chil-
dren <2 years may be related to force of infection related 
to low body surface area [21], increased use of LLINs in 
this age group [22], or the fact young children are more 
likely to become symptomatic and be treated for malaria.
Across all sites, the change in parasite prevalence with 
sub-microscopic detection of parasites was most strik-
ing in adults, with the prevalence of parasitaemia six- to 
ten-fold higher when considering LAMP results. In the 
highest transmission setting, Nagongera, the addition of 
sub-microscopic data for persons ≥18 years old increased 
the prevalence of parasitaemia from 5 to over 50 %, giv-
ing adults a prevalence similar to that of infants. This 
study demonstrates that among parasitaemic individuals 
there is a significant association between age ≥18 years 
and prevalence of sub-microscopic parasitaemia. This 
finding is consistent with a recently published review of 
malaria diagnostics, which describes adults as having the 
highest proportion of subpatent infections, regardless 
of transmission intensity [3]. Adults, if parasitaemic, are 
more likely to have lower density infections, likely related 
to acquired partial immunity in adulthood and the abil-
ity of the adult immune system to suppress blood-stage 
parasites [23, 24].
Table 5 Associations between parasitaemia status and mean haemoglobin, stratified by age and study site



























11.4 (1.7) 0.96 (0.94–0.97) <0.001 12.0 (1.6) 0.94 (0.93–0.95) <0.001 11.6 (1.5) 0.97 (0.96–0.98) <0.001
Microscopic 
parasitaemia








13.0 (1.8) 0.98 (0.97–1.00) 0.13 12.8 (1.6) 0.95 (0.93–0.98) <0.001 13.2 (1.7) 0.99 (0.98–1.01) 0.20
Microscopic 
parasitaemia
12.9 (1.8) 0.95 (0.91–0.99) 0.008 12.4 (2.2) 0.93 (0.88–0.98) 0.01 13.5 (1.6) 0.99 (0.96–1.02) 0.46
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Being diagnosed and treated for malaria in the previ-
ous 30  days was associated with a greater prevalence 
of sub-microscopic parasitaemia among those who 
were parasitaemic. This effect reflects the sensitivity of 
LAMP as a diagnostic test and may be due to residual 
low-density asexual parasitaemia, persistence of mature 
gametocytes following treatment, amplification of DNA 
from non-viable parasites, or suppression of recurrent 
parasite infection by lumefantrine. The phenomenon of 
residual sub-microscopic parasitaemia and gametocy-
taemia following treatment with ACT has been previ-
ously described [25, 26], but the transmission potential of 
recently treated individuals remains an area that is poorly 
understood.
Both sub-microscopic and microscopic parasitae-
mia are associated with reduced mean haemoglobin, as 
supported by the results of this study. The association 
between acute episodes of malaria and anaemia is well 
described, with cumulative episodes of haemolysis lead-
ing to impairments in red cell production [27, 28]. The 
association between parasitaemia and anaemia is less 
clear, although it has been described in children with 
both microscopic and sub-microscopic parasitaemia 
[29, 30]. The results of this study demonstrate signifi-
cantly lower mean haemoglobin in children with both 
sub-microscopic and microscopic parasitaemia, com-
pared to the group with no detectable parasitaemia. 
Adults showed a similar trend in lower transmission 
sites, although this pattern was not observed in highest 
transmission site. Anaemia is multifactorial and the anal-
ysis of this study did not take into account factors such 
as genetic polymorphisms, nutrition, parity, or helminth 
infection, nor did it assess cumulative effects of malaria 
on an individual. Furthermore, the study design does not 
allow evaluation of causality between parasitaemia and 
anaemia. However, this study joins a body of work sug-
gesting deleterious clinical consequences of parasitaemia 
of any level and suggests that the term ‘asymptomatic 
infection’ may be a misnomer [31, 32].
This study had several limitations. Although the 
results demonstrate that people with sub-microscopic 
infection make up a large part of the parasite reser-
voir, the transmission potential of these individuals is 
unclear. There are data supporting mosquito infectiv-
ity of sub-microscopic parasitaemia [8], however fur-
ther work is needed to clarify the relative contribution 
of sub-microscopic infections to onward transmis-
sion. Given the complex interplay of host factors and 
repeated parasitaemia, longitudinal analysis is needed 
to characterize the effect of parasitaemia on clinical 
outcomes, including anaemia. Finally, there is no way to 
differentiate between chronic and repeated infections in 
this study. Given the likelihood of multiple co-infecting 
strains of malaria, as well as data that suggest infections 
may be harboured in individuals for extended periods 
of time [33, 34], genotyping in future studies would be 
helpful and enable a better understanding of infection 
dynamics.
Conclusion
This study demonstrates that the majority of individuals 
with detectable malaria parasitaemia have sub-micro-
scopic infection, among all ages and across a variety of 
transmission intensities in Uganda. Among those with 
parasitaemia, adults and persons recently treated with 
anti-malarial therapy had the highest prevalence of sub-
microscopic infection. These data should inform the 
discussion of malaria control efforts in high-transmis-
sion settings, where addressing sub-microscopic parasi-
taemia is needed to make meaningful progress towards 
improved malaria control and eventual elimination.
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